Paeds Cases · mental-behavioural-and-psychosomatic
Chronic fatigue and post-viral fatigue syndromes OSCE — validation, energy management and school reintegration
Observed structured encounter testing a validating, function-first chronic-fatigue consultation: biopsychosocial assessment, recognising post-exertional malaise, excluding mimics once, explaining the energy envelope, an individualised management plan with CBT, declining rigid graded exercise, and a graded return-to-school.
On this page & tools
Target exams
Station objectives
- Validate chronic fatigue as a real, multi-system illness and recognise post-exertional malaise as the hallmark. [1]
- Distinguish CFS/ME from depression and deconditioning, and confirm the focused exclusion of mimics. [1]
- Co-build a function-first plan — energy management within the energy envelope, CBT, individualised activity. [2]
- Decline rigid graded exercise clearly and empathically, and treat school reintegration as a clinical outcome. [4] [6]
Candidate brief
You are the paediatric doctor in adolescent clinic. You have 10 minutes for Station A (post-glandular-fever fatigue, half-days at school, father wants her to push through) and 12 minutes for Station B (established CFS/ME with new weight loss and night sweats, family told it is part of her syndrome). Examiners score validation, recognition of PEM, function-first framing, and partnership language. [1] [6]
Station A — Post-viral fatigue, half-days at school, father wants her to push through
Setup: A 14-year-old, four months after confirmed EBV infection. Fatigue, 11 hours of unrefreshing sleep, and a two-day crash after PE. Attending school only half-days. Targeted bloods normal. She desperately wants to return to sport and friends. Her father believes she should push through with a structured exercise programme. [1]
Expected actions:
- Greet the adolescent first; see her alone; state conditional confidentiality with its lawful limits. [1]
- Validate the fatigue as a real, multi-system illness and not her fault; take a fatigue and activity history and a HEEADSSS-tailored psychosocial history; screen for suicidality. [1]
- Identify and name post-exertional malaise as the discriminating feature; confirm the focused blood exclusion is complete and avoid a further cascade. [1]
- Explain the energy envelope and pacing; co-build a function-first plan: energy management, CBT, individualised activity, graded return-to-school. Set functional goals, not a cure promise. [2]
- Respond to the father's "push through" request directly and empathically: explain that rigid graded exercise can trigger PEM and that current guidance withdrew fixed-dose GET; activity is escalated only as tolerated, with her in control. [4]
Station B — Established CFS/ME with new weight loss and night sweats
Setup: A 15-year-old with established CFS/ME managed for eight months with energy management and CBT, now attending school four days a week. She presents with new weight loss, night sweats and a palpable cervical node. The family has been told by a clinician that this is "part of her fatigue syndrome." [6]
Expected actions:
- Validate the family's concern and take a targeted history of the new symptoms; do not attribute them to the CFS/ME label. [1]
- Name diagnostic overshadowing explicitly: new red flags are reassessed on their own merits regardless of an existing functional diagnosis. [1]
- Re-enter the diagnostic pathway with targeted investigation — inflammatory markers, LDH, directed imaging, considering malignancy and inflammatory illness — and arrange prompt review. [1]
- Reassure the family that you are taking the new symptoms seriously while continuing the function-first plan if organic disease is again excluded; document the reasoning and the safety-net. [6]
- Address the school trajectory positively — she has improved to four days a week — and continue the graded, school-led return-to-school plan. [6]
Marking anchors
Clear pass: validates the illness as real; recognises and defines PEM; confirms the focused exclusion of mimics; co-builds a function-first plan with energy management and CBT; declines rigid graded exercise clearly and empathically; treats school reintegration as a clinical outcome; in Station B, immediately recognises the red flags and avoids diagnostic overshadowing. [1] [2] [4] [6] Borderline: validates well but defers school reintegration to "later," offers vague follow-up, or avoids the graded-exercise conversation. Fail: dismisses the fatigue as stress or laziness; prescribes a fixed graded-exercise increment for all; promises a cure; ignores the new red flags in Station B; uses stigmatising language. [1]
Debrief pearls
- The explanation of PEM and the energy envelope is itself a treatment — it changes the trajectory. [1]
- Energy management within the envelope, not push-through exercise, is the active treatment. [4]
- School attendance is a clinical outcome, not an administrative detail. [6]
- A functional label never exempts a new red flag from investigation. [1]
References
- [1]Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AC, Speight N, Vallings R, Bateman L Myalgic encephalomyelitis: International Consensus Criteria. Journal of internal medicine, 2011.PMID 21777306
- [2]Nijhof SL, Bleijenberg G, Uiterwaal CS, Kimpen JL, van de Putte EM Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet (London, England), 2012.PMID 22385683
- [4]Larun L, Brurberg KG, Odgaard-Jensen J, Price JR Exercise therapy for chronic fatigue syndrome. The Cochrane database of systematic reviews, 2019.PMID 31577366
- [5]Collin SM, Norris T, Nuevo R, Tilling K, Joinson C, Sterne JA, Crawley E Chronic Fatigue Syndrome at Age 16 Years. Pediatrics, 2016.PMID 26810786
- [6]Moore Y, Serafimova T, Anderson N, King H, Richards A, Brigden A, Sinai P, Higgins J, Ascough C, Clery P, Crawley EM Recovery from chronic fatigue syndrome: a systematic review-heterogeneity of definition limits study comparison. Archives of disease in childhood, 2021.PMID 33846138